Education
About Us
Working with TipRanks
Follow Us
Christopher Kim Insider Profile
4 Followers
Christopher Kim, Chairman and CMO, Director at Apimeds Pharmaceuticals US, Inc., holds 277.50K shares in Apimeds Pharmaceuticals US, Inc. (Ticker: APUS).
Christopher Kim has not reported sufficient informative transactions and therefore cannot be ranked.
Time Frame
Compare to
Insider Holdings
100.00%
A breakdown of Christopher Kim's holdings
Insider Roles
Chairman and CMO, Director
Roles that Christopher Kim holds in companies
Most Profitable Insider Trade
Stock:
Rating:Informative Buy
Date:May 15, 2025 - Today
Return:+6.30%
The most profitable trade made by Christopher Kim
Christopher Kim's Trading History
List of latest transactions for each holding click on a transaction to see Christopher Kim's performance on stock
You May Also Like
Christopher Kim insider profile FAQ
What is the percentage of profitable transactions made by Christopher Kim?
The percentage of profitable transactions made by Christopher Kim is ―.
What is the average return per transaction made by Christopher Kim?
The average return per transaction made by Christopher Kim is ―.
What stocks does Christopher Kim hold?
Christopher Kim holds: APUS stocks.
What was Christopher Kim’s latest transaction?
Christopher Kim latest transaction was an Uninformative Buy of ―.
What was Christopher Kim's most profitable transaction?
Christopher Kim’s most profitable transaction was an Informative Buy of APUS stock on May 15, 2025. The return on the trade was 6.30%.
What is Christopher Kim's role in Apimeds Pharmaceuticals US, Inc.?
Christopher Kim's role in Apimeds Pharmaceuticals US, Inc. is Chairman and CMO, Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.